Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels.
Alessandro MengozziSarah CostantinoFrancesco PaneniEmiliano DurantiMonica NannipieriRudj ManciniMichele LaiVeronica La RoccaIlaria PuxedduLuca AntonioliMatteo FornaiMarco GhionzoliGeorgios GeorgiopoulosChiara IppolitoNunzia BernardiniFrank RuschitzkaNicola Riccardo PuglieseStefano TaddeiAgostino VirdisStefano MasiPublished in: Circulation research (2022)
and Arginase II, it influences mtROS levels, NO availability, and the expression of proteins of the mitochondria respiratory chain. Therapeutic modulation of SIRT1 restores obesity- and age-related endothelial dysfunction. Early targeting of SIRT1 might represent a crucial strategy to prevent age- and obesity-related microvascular dysfunction.
Keyphrases
- insulin resistance
- oxidative stress
- metabolic syndrome
- weight loss
- high fat diet induced
- weight gain
- type diabetes
- ischemia reperfusion injury
- endothelial cells
- poor prognosis
- diabetic rats
- cancer therapy
- high glucose
- adipose tissue
- cell death
- mouse model
- skeletal muscle
- nitric oxide
- body mass index
- reactive oxygen species
- induced pluripotent stem cells
- drug delivery
- pluripotent stem cells